219 related articles for article (PubMed ID: 33042409)
1. Construction of a prognostic model based on nine immune-related genes and identification of small molecule drugs for hepatocellular carcinoma (HCC).
Zhang J; Chen G; Zhang J; Zhang P; Ye Y
Am J Transl Res; 2020; 12(9):5108-5130. PubMed ID: 33042409
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
3. Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma.
Zhu Z; Song M; Li W; Li M; Chen S; Chen B
Front Oncol; 2021; 11():695001. PubMed ID: 34616672
[TBL] [Abstract][Full Text] [Related]
4. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients.
Ye D; Liu Y; Li G; Sun B; Peng J; Xu Q
Front Oncol; 2021; 11():766072. PubMed ID: 34868990
[TBL] [Abstract][Full Text] [Related]
5. A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
J Hepatocell Carcinoma; 2021; 8():119-132. PubMed ID: 33758763
[TBL] [Abstract][Full Text] [Related]
6. Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma.
Song ZB; Yu Y; Zhang GP; Li SQ
Front Cell Dev Biol; 2021; 9():728574. PubMed ID: 34676211
[TBL] [Abstract][Full Text] [Related]
7. A Prognostic Autophagy-Related Gene Pair Signature and Small-Molecule Drugs for Hepatocellular Carcinoma.
Song Z; Zhang G; Yu Y; Li S
Front Genet; 2021; 12():689801. PubMed ID: 34497633
[TBL] [Abstract][Full Text] [Related]
8. Co-amplification of genes in chromosome 8q24: a robust prognostic marker in hepatocellular carcinoma.
Zheng Y; Cheng Y; Zhang C; Fu S; He G; Cai L; Qiu L; Huang K; Chen Q; Xie W; Chen T; Huang M; Bai Y; Pan M
J Gastrointest Oncol; 2021 Jun; 12(3):1086-1100. PubMed ID: 34295559
[TBL] [Abstract][Full Text] [Related]
9. Exploring potential targets of Actinidia chinensis Planch root against hepatocellular carcinoma based on network pharmacology and molecular docking and development and verification of immune-associated prognosis features for hepatocellular carcinoma.
Qu M; Han T; Chen X; Sun Q; Li Q; Zhao M
J Gastrointest Oncol; 2022 Jun; 13(3):1289-1307. PubMed ID: 35837167
[TBL] [Abstract][Full Text] [Related]
10. Systematic Construction and Validation of a Prognostic Model for Hepatocellular Carcinoma Based on Immune-Related Genes.
Yu J; Ma S; Tian S; Zhang M; Ding X; Liu Y; Yang F; Hu Y; Xuan G; Zhou X; Wang J; Han Y
Front Cell Dev Biol; 2021; 9():700553. PubMed ID: 34671598
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma.
Xia X; Tang P; Liu H; Li Y
J Clin Transl Hepatol; 2021 Dec; 9(6):798-808. PubMed ID: 34966643
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of prognostic signature for hepatocellular carcinoma basing on hepatitis B virus related specific genes.
Wang L; Qiu M; Wu L; Li Z; Meng X; He L; Yang B
Infect Agent Cancer; 2022 Dec; 17(1):60. PubMed ID: 36474267
[TBL] [Abstract][Full Text] [Related]
13. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
14. A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma.
Zhang G; Su L; Lv X; Yang Q
Cancer Cell Int; 2021 Oct; 21(1):522. PubMed ID: 34627241
[TBL] [Abstract][Full Text] [Related]
15. A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma.
Huang Y; Chen S; Qin W; Wang Y; Li L; Li Q; Yuan X
Front Oncol; 2020; 10():580513. PubMed ID: 33251144
[TBL] [Abstract][Full Text] [Related]
16. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Li W; Lu J; Ma Z; Zhao J; Liu J
Front Genet; 2019; 10():1323. PubMed ID: 32010188
[No Abstract] [Full Text] [Related]
17. Comprehensive Analysis to Identify the Epithelial-Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma.
Wu G; Yang Y; Zhu Y; Li Y; Zhai Z; An L; Liu M; Zheng Y; Wang Y; Zhou Y; Guo Q
Front Surg; 2021; 8():742443. PubMed ID: 34722623
[No Abstract] [Full Text] [Related]
18. Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis.
Liu P; Wei J; Mao F; Xin Z; Duan H; Du Y; Wang X; Li Z; Qian J; Yao J
Front Oncol; 2021; 11():641487. PubMed ID: 34094926
[TBL] [Abstract][Full Text] [Related]
19. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma.
Bian J; Long J; Yang X; Yang X; Xu Y; Lu X; Guan M; Sang X; Zhao H
Ann Transl Med; 2021 May; 9(9):765. PubMed ID: 34268378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
